Al Masri Dana, Fleifel Mohamad, Hirbli Kamal
Endocrinology, Diabetes, and Metabolism, Lebanese American University Medical Center, Beirut, LBN.
Internal Medicine, Lebanese American University Medical Center, Beirut, LBN.
Cureus. 2021 Oct 8;13(10):e18599. doi: 10.7759/cureus.18599. eCollection 2021 Oct.
We report a case of fixed drug eruption in a 58-year-old lady treated for diabetes with four pharmacologically different anti-diabetic agents that were used at separate times of therapy. Skin manifestations, including erythema, blisters, and ulcers, developed over the right leg each time after the initiation of metformin, gliclazide, vildagliptin, and empagliflozin; and disappeared following the discontinuation of the drugs. Magnesium stearate was the common excipient identified in the four agents. This is an extremely rare case of fixed drug eruption caused by structurally dissimilar drugs.
我们报告了一例58岁女性的固定性药疹病例,该患者因糖尿病接受了四种药理作用不同的抗糖尿病药物治疗,这些药物在不同治疗阶段使用。每次在开始使用二甲双胍、格列齐特、维格列汀和恩格列净后,右腿都会出现包括红斑、水疱和溃疡在内的皮肤表现;停药后这些表现消失。硬脂酸镁是这四种药物中鉴定出的常见辅料。这是一例由结构不同的药物引起的极为罕见的固定性药疹病例。